Rapid Micro Biosystems Raises $9.8M, Could Total $32M With Warrants
Rapid Micro Biosystems priced an offering of 3.58 million Class A shares with Series A warrants at $1.955 per unit, raising $9.8 million. Full exercise of Series A and B warrants could generate an additional $21.7 million, bringing total potential proceeds to approximately $32 million.
1. Offering Details
Rapid Micro Biosystems sold 3.581 million Class A shares with accompanying Series A and Series B warrants at $1.955 per combined unit, along with pre-funded warrants for up to 1.463 million additional shares at $1.945 per unit.
2. Investor Participation
Bain Capital Life Sciences and Armistice Capital invested $9.8 million in the offering, while certain directors and officers purchased 71,607 shares plus related warrants in a concurrent registered direct offering.
3. Proceeds and Closing
The offering is expected to provide $9.8 million in gross proceeds, with an additional $21.7 million available if all warrants are exercised, for total funding of about $32 million. The transaction is slated to close on May 20, 2026, subject to customary conditions.
4. Warrant Structure
Series A warrants carry an exercise price of $1.955 per share, exercisable six months after issuance and expiring one year later; Series B warrants carry a $2.34 exercise price, exercisable after six months and expiring five years after issuance.